Parameter estimates for trends and patterns of excess mortality among persons on ART in high-income european settings

Archive ouverte

Trickey, A. | van Sighem, A. | Stover, J. | Abgrall, S. | Grabar, S. | Bonnet, Fabrice | Berenguer, J. | Wyen, C. | Casabona, J. | d'Arminio Monforte, A. | Cavassini, M. | del Amo, J. | Zangerle, R. | Gill, M. J. | Obel, N. | Sterne, J. A. C. | May, M. T.

Edité par CCSD ; Wolters Kluwer -

International audience. INTRODUCTION: HIV cohort data from high-income European countries were compared to the UNAIDS Spectrum modelling parameters for these same countries to validate mortality rates and excess mortality estimates for people living with HIV (PLHIV) on antiretroviral therapy (ART). METHODS: Data from 2000-2015 were analysed from the Antiretroviral Therapy Cohort Collaboration (ART-CC) for Austria, Denmark, France, Italy, the Netherlands, Spain, and Switzerland. Flexible parametric models were used to compare All-cause mortality rates in the ART-CC and Spectrum. The percentage of AIDS-related deaths and excess mortality (both are the same within Spectrum) were compared, with excess mortality defined as that in excess of the general population mortality.RESULTS: Analyses included 94026 PLHIV with 585784 person-years of follow-up, from which there were 5515 deaths. All-cause annual mortality rates in Spectrum for 2000-2003 were 0.0121, reducing to 0.0078 in 2012-2015, whilst the ART-CC's corresponding annual mortality rates were 0.0151 (95% confidence interval [95%CI]: 0.0130-0.0171) reducing to 0.0049 (95%CI: 0.0039-0.0060). The percentage of AIDS-related deaths in Spectrum was 74.7% in 2000-2003, dropping to 43.6% in 2012-15. In the ART-CC, AIDS-related mortality comprised 45.3% (95%CI: 38.4%-52.9%) of mortality in 2000-2003 and 26.7% (95%CI: 19.0%, 46.0%) between 2012-2015. Excess mortality in the ART-CC was broadly similar to the Spectrum estimates, dropping from 75.3% (95%CI: 60.3%-95.2%) in 2000-2003 to 30.7% (95%CI: 25.5%-63.7%) in 2012-2015.CONCLUSIONS: All-cause mortality assumptions for PLHIV on ART in high-income European settings should be adjusted in Spectrum to be higher in 2000-2003 and decline more quickly to levels currently captured for recent years.

Suggestions

Du même auteur

Cervical cancer risk in women living with HIV across four continents: A multicohort study. : Int J Cancer

Archive ouverte | Rohner, E. | CCSD

International audience. We compared invasive cervical cancer (ICC) incidence rates in Europe, South Africa, Latin and North America among women living with HIV who initiated antiretroviral therapy (ART) between 1996...

Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio

Archive ouverte | Hughes, R. A. | CCSD

International audience. OBJECTIVE: Model trajectories of CD4 and CD8 cell counts after starting combination antiretroviral therapy (ART), and use the model to predict trends in these counts and the CD4:CD8 ratio. DE...

The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post–Combination Antiretroviral Therapy Era

Archive ouverte | Mocroft, Amanda | CCSD

International audience. Background. Few studies consider the incidence of individual AIDS-defining illnesses (ADIs) at higher CD4 counts, relevant on a population level for monitoring and resource allocation.Methods...

Chargement des enrichissements...